Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: IBI305 ×

IBI305

This drug is selected. Its supporting articles are shown below.

Articles mentioning IBI305

1 articles · page 1 of 1

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial

bmjopen · abstract · 2026-01-09 · 3 matching annotations

96.9%

IBI305 sintilimab capecitabine CapeOX oxaliplatin bevacizumab gastric or gastro-oesophageal junction (G/GEJ) cancer chemotherapy G/GEJ

…, the patients will receive CapeOX combined with sintilimab and IBI305 at the recommended phase II dose. The primary objectives will b…